ELAB
Price
$4.84
Change
+$0.18 (+3.86%)
Updated
Sep 3 closing price
Capitalization
3.34M
LXRX
Price
$1.08
Change
-$0.04 (-3.57%)
Updated
Sep 3 closing price
Capitalization
394.29M
56 days until earnings call
Interact to see
Advertisement

ELAB vs LXRX

Header iconELAB vs LXRX Comparison
Open Charts ELAB vs LXRXBanner chart's image
PMGC Holdings
Price$4.84
Change+$0.18 (+3.86%)
Volume$130.52K
Capitalization3.34M
Lexicon Pharmaceuticals
Price$1.08
Change-$0.04 (-3.57%)
Volume$1.19M
Capitalization394.29M
ELAB vs LXRX Comparison Chart in %
Loading...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAB vs. LXRX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAB is a StrongBuy and LXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ELAB: $4.66 vs. LXRX: $1.12)
Brand notoriety: ELAB and LXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELAB: 4% vs. LXRX: 110%
Market capitalization -- ELAB: $3.34M vs. LXRX: $394.29M
ELAB [@Biotechnology] is valued at $3.34M. LXRX’s [@Biotechnology] market capitalization is $394.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAB’s FA Score shows that 1 FA rating(s) are green whileLXRX’s FA Score has 1 green FA rating(s).

  • ELAB’s FA Score: 1 green, 4 red.
  • LXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, LXRX is a better buy in the long-term than ELAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAB’s TA Score shows that 4 TA indicator(s) are bullish while LXRX’s TA Score has 2 bullish TA indicator(s).

  • ELAB’s TA Score: 4 bullish, 6 bearish.
  • LXRX’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both ELAB and LXRX are a bad buy in the short-term.

Price Growth

ELAB (@Biotechnology) experienced а -34.41% price change this week, while LXRX (@Biotechnology) price change was -1.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

LXRX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LXRX($394M) has a higher market cap than ELAB($3.34M). LXRX YTD gains are higher at: 51.659 vs. ELAB (-91.694). LXRX has more cash in the bank: 139M vs. ELAB (5.68M). ELAB has less debt than LXRX: ELAB (103K) vs LXRX (57M).
ELABLXRXELAB / LXRX
Capitalization3.34M394M1%
EBITDAN/A-107.44M-
Gain YTD-91.69451.659-177%
P/E Ratio0.04N/A-
RevenueN/A58.4M-
Total Cash5.68M139M4%
Total Debt103K57M0%
FUNDAMENTALS RATINGS
LXRX: Fundamental Ratings
LXRX
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELABLXRX
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 17 days ago
87%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPL0.800.03
+4.43%
Solitario Resources Corp
WCC219.00-0.84
-0.38%
Wesco International
HLMN9.83-0.05
-0.51%
Hillman Solutions Corp
CRNC9.80-0.73
-6.93%
Cerence
JFBR4.70-0.44
-8.51%
Jeffs Brands Ltd

ELAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAB has been loosely correlated with EPIX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAB jumps, then EPIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
-17.81%
EPIX - ELAB
35%
Loosely correlated
-0.50%
CRBP - ELAB
30%
Poorly correlated
+3.95%
LXRX - ELAB
21%
Poorly correlated
+1.82%
EDSA - ELAB
21%
Poorly correlated
+0.91%
CLNN - ELAB
21%
Poorly correlated
+20.11%
More

LXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXRX has been loosely correlated with PLRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LXRX jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXRX
1D Price
Change %
LXRX100%
+1.82%
PLRX - LXRX
39%
Loosely correlated
+2.13%
OCUL - LXRX
36%
Loosely correlated
+4.01%
RAPP - LXRX
36%
Loosely correlated
-7.15%
TECH - LXRX
34%
Loosely correlated
-2.21%
EPIX - LXRX
34%
Loosely correlated
-0.50%
More